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Abstract
Background: CRISPR-Cas systems provide adaptive immunity to mobile genetic elements in prokaryotes. In many
bacteria, including E. coli, a specialized ribonucleoprotein complex called Cascade enacts immunity by“ an
interference reaction" between CRISPR encoded RNA (crRNA) and invader DNA sequences called “protospacers”.
Cascade recognizes invader DNA via short “protospacer adjacent motif” (PAM) sequences and crRNA-DNA
complementarity. This triggers degradation of invader DNA by Cas3 protein and in some circumstances stimulates
capture of new invader DNA protospacers for incorporation into CRISPR as “spacers” by Cas1 and Cas2 proteins,
thus enhancing immunity. Co-expression of Cascade, Cas3 and crRNA is effective at giving E. coli cells resistance to
phage lysis, if a transcriptional repressor of Cascade and CRISPR, H-NS, is inactivated (Δhns). We present further
genetic analyses of the regulation of CRISPR-Cas mediated phage resistance in Δhns E. coli cells.
Results: We observed that E. coli Type I-E CRISPR-Cas mediated resistance to phage λ was strongly temperature
dependent, when repeating previously published experimental procedures. Further genetic analyses highlighted
the importance of culture conditions for controlling the extent of CRISPR immunity in E. coli. These data identified
that expression levels of cas3 is an important limiting factor for successful resistance to phage. Significantly, we
describe the new identification that cas3 is also under transcriptional control by H-NS but that this is exerted only
in stationary phase cells.
Conclusions: Regulation of cas3 is responsive to phase of growth, and to growth temperature in E. coli, impacting
on the efficacy of CRISPR-Cas immunity in these experimental systems.
Keywords: CRISPR-Cas, H-NS, PAM, HtpG, Temperature, E. coli
Background
Escherichia coli K-12 utilises Type I-E CRISPR (Clustered
Regularly Interspaced Short Palindromic Repeats) loci to
gain immunity to invasive DNA such as bacteriophage
(“phage”), dependent on activities of Cas (CRISPR-associ-
ated) proteins reviewed in [1–5]. CRISPR loci are com-
posed of the AT-rich leader region followed by arrays of
sequence repeats separated by spacers that are homolo-
gous to sequences of invading DNA (“protospacers”).
CRISPR arrays are transcribed into “pre-crRNA” that is
further processed into “crRNA” that contains a full or par-
tial spacer sequence reviewed in [1–5]. In E. coli, crRNA
assembled into “Cascade” (CRISPR-associated complex
for antiviral defence) is targeted to protospacers in “inter-
ference” reactions. E. coli Cascade comprises five proteins:
Cse1 (CasA), Cse2 (CasB), Cas7 (CasC), Cas5 (CasD) and
Cas6e (CasE) [6–10]. Interference generates base pairing
between crRNA and protospacer DNA in an R-loop, dis-
placing the DNA strand that is not complementary to
crRNA [6, 11–15]. This single stranded DNA is degraded
by Cas3 helicase-nuclease [16–19].
Cascade catalyses interference R-loops by a sequential
process reliant on recognition of protospacer adjacent
motif (PAM) sequences located immediately next to a
protospacer on the target protospacer DNA [20–23].
CRISPR arrays lack a PAM sequence, helping to prevent
targeting of self-DNA by Cascade [24–26]. In E. coli K-12
PAM 5′-CTT-3′ is most prevalent (80 %) [22, 26, 27], and
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of 64 possible PAMs, five PAMs are tolerated by Cascade
to promote interference [11, 22, 25]. The Cse1 (CasA)
subunit of Cascade is important for PAM recognition, and
for positioning Cas3 to degrade invader DNA [13, 16, 19].
After PAM recognition, stable R-loop formation requires
complementarity between the crRNA-DNA in a “seed” re-
gion (8-10 nucleotides from the 5′ end of the crRNA spa-
cer sequence). Upon reaching the end of the protospacer
the R-loop becomes locked [28] and by pushing Cse2
dimer it induces repositioning of Cse1 and Cse2 proteins,
and conformational change of the whole Cascade complex
[29]. After locking of the R-loop, additional PAM verifica-
tion guides Cas3 binding near the PAM [13, 19, 29] and
degradation of the DNA [11, 15, 29].
“Escape” mutations in phage DNA can reduce the sta-
bility of E. coli Cascade R-loops when they arise in a
protospacer seed or a PAM, and correspond to reduced
resistance to plaque formation [11, 21–23, 25, 30, 31].
Other mutations in phage DNA protospacers are toler-
ated for interference (e.g. positions 6, 12, 18, 24, 30)
[22]. This is because five Cas7 proteins fold over every
sixth nucleotide of the crRNA which are flipped outward
and do not participate in DNA recognition [8–10]. Re-
cent results showed that the crRNA spacer sequence
also has significant role in helping interference machin-
ery to recognize protospacer with single point mutations
within the seed sequence or PAM [32]. Escape mutations
that block interference promote rapid acquisition of new
spacers from the same target DNA, a process called
‘primed’ adaptation that suggests cross-talk between
Cas1-Cas2 DNA capture and alternative binding mode
of Cascade that promotes priming [22, 27, 31]. Primed
adaptation is a very robust process that tolerates up to
13 mutations either in PAM or protospacer region [22].
Spacers newly acquired during primed adaptation there-
fore provide elevated protection against invader whose
escape mutations were evading robust interference by
Cascade [27, 32].
In E. coli H-NS (nucleoid-structuring protein) re-
presses transcription of CRISPR and the genes encoding
Cascade, Cas1 and Cas2. E. coli LeuO de-represses tran-
scription of genes encoding Cascade, by blocking co-
operative spreading of H-NS along the promoter of the
initially transcribed Cascade gene, cse1 [33, 34]. In
addition to H-NS and LeuO, CRP (cAMP receptor pro-
tein) is a transcriptional repressor of cas genes in E. coli
[35, 36]. The CRP binding site in this case overlaps with
the LeuO binding site, leading to the proposal that
CRP and LeuO compete for binding to the cse1 pro-
moter depending on the cellular availability of cAMP
[35]. In contrast to the apparent complexity of tran-
scriptional regulation of Cascade and CRISPR, factors
that control transcription of E. coli cas3 have not
been identified.
Experimental analyses of CRISPR-Cas in E. coli can over-
come influences of H-NS, LeuO and CRP repression by
engineering inducible expression of CRISPR, Cascade and
Cas3 from plasmids or their chromosomal loci [27, 37].
Deletion of H-NS (Δhns), or ectopic over-expression of
LeuO in cells with engineered anti-λ spacer (λT3) into
CRISPR, promote CRISPR interference observed as en-
hanced resistance to phage λvir [34, 38]. In these studies
the protospacer targeted by spacer λT3 crRNA had a non-
consensus PAM 5′-CCA-3′ and although resistance to
phage λvir from these strains was effective at 30 °C, we no-
ticed that at 37 °C cells became sensitive to plaque forma-
tion. We investigated this further in Δhns cells that had
acquired a new spacer (λc) targeting protospacer with the
consensus PAM 5′-CTT-3′. We report that the effect of
temperature on CRISPR immunity in these E. coli cells was
correlated to expression of Cas3 and its chaperone HtpG
(high-temperature protein G). Inducible ectopic expression
of Cas3 in the presence, but not absence, of chromosomal
htpG rescued resistance to phage at 37 °C. Further research
will be required to uncover how temperature causes this
effect on activity of the E. coli CRISPR-Cas system.
Results
Temperature-dependent resistance of Δhns E. coli cells to
phage λvir is not caused by PAM sequence variation
Genetic analysis of E. coli CRISPR-Cas in previous stud-
ies established that H-NS represses transcription of the
operon encoding Cascade, Cas1-Cas2 (casABCDE12)
and CRISPR locus 2.1 [33–35, 38]. Deleting H-NS
(Δhns) from cells de-repressed transcription, and effi-
cient resistance to λvir infection at 30 °C was reported
when CRISPR of Δhns cells was engineered to contain
an anti-λ phage spacer sequence (λT3) [34, 38]. The im-
portance of the λT3 spacer was highlighted by sensitivity
of Δhns cells to λvir plaque formation compared to
Δhns + λT3 cells [38]. When repeating these experiments
we also observed about 100000 fold elevated resistance
of Δhns + λT3 cells to λvir infection at 30 °C, compared
to Δhns cells without λT3 spacer (Table 1). However at
37 °C, in otherwise identical assays, Δhns + λT3 cells be-
came sensitive to phage (Table 1). Cells with intact H-
NS (hns+), with or without λT3, were sensitive to λvir
infection at both temperatures (Table 1). There was no
difference in sensitivity at 37 °C between Δhns cells + or -
λT3 spacer. If λT3 spacer was absent from the CRISPR
locus 2.1, Δhns cells showed threefold increase in resistance
at 30 °C in comparison to 37 °C (Table 1). Therefore using
30 °C temperature of incubation in infectivity assays is an
important factor for promoting resistance of Δhns + λT3
cells to phage λvir.
The λT3 spacer sequence engineered into CRISPR
used here and in [37, 38] has a nucleotide sequence
match with the template strand of λ phage gene lysis R,
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but the PAM sequence (5′-CCA-3′, Additional file 1:
Figure S1A) deviates from consensus 5′-CTT-3′ E. coli
PAM [20]. Single nucleotide variations in PAMs may
disrupt interference in Type I-E, I-F and Type II CRISPR
systems by preventing R-loop priming and degradation
of invading DNA [21, 22, 25, 29, 30, 39, 40]. Five
PAMs, CAT, CTT, CCT, CTC and CTA found previ-
ously [11, 22, 25], are utilized by Cascade for robust
interference, and ten non-consensus PAMs give a partial
resistance phenotype [25]. Therefore, PAM 5′-CCA-3′ be-
longs to the latter group, giving partial resistance to λvir
as expected from previous data [25]. However, recent find-
ings showed that spacer sequence dictates whether mutant
PAM sequences will be tolerated for interference or not
[32]. We investigated if the observed major difference in
phage resistance of Δhns cells at 30 °C and 37 °C was re-
lated to PAM sequence by introducing spacer targeting
protospacer with the consensus PAM 5′-CTT-3′ into
CRISPR. To do this we provoked Δhns + λT3 E. coli to ac-
quire a new spacer. One such E. coli derivative containing
spacer (λc) targeting phage λvir gene cII with a 5′-CTT-3′
PAM was selected. The procedure is detailed in the
methods and supplementary material. The constructed
strain (IIB1039; Table 2) also contains Δcas1 mutation as
a useful controlling factor to uncouple interference from
adaptation, enabling focus on interference reaction only.
In phage infectivity assays, hns+ Δcas1 + λc + λT3 cells
were sensitive to λvir phage at 30 °C and 37 °C, as ex-
pected because H-NS represses cas genes (Table 3). Δhns
Δcas1 + λc + λT3 cells showed ~108 fold increase in re-
sistance at 30 °C compared to hns+ Δcas1 + λc + λT3,
and ~103 compared to Δhns Δcas1 + λT3 cells, but
remained sensitive to λvir infection at 37 °C (Table 3).
This showed that Δcas1 mutation did not affect interfer-
ence as expected and confirmed the importance of a con-
sensus PAM for phage resistance in infectivity assays at
30 °C, explained in previous studies by the effect of vari-
able PAMs on efficacy of interference reactions [25, 29].
However, added spacer targeting the consensus PAM 5′-
CTT-3′ was not able to repeal the temperature dependent
resistance of Δhns cells to λvir in these assays, which we
concluded must be caused by other factor (s).
Transcription and stability of cas3 in Δhns cells is limiting
for resistance to phage
We tested if the effect of temperature on phage resist-
ance was influenced by variations in expression of E. coli
CRISPR-Cas. Robust resistance of Δhns Δcas1 + λc + λT3
cells to λvir (Table 3) suggested all components of
CRISPR-Cas were expressed in sufficient amounts at
30 °C. A previous analysis identified increased transcrip-
tion of genes encoding Cascade and crRNA in Δhns cells
grown to mid-log phase, but no such increase in cas3
transcripts [34]. We explored if levels of Cas3 RNA or
protein in cells might correlate to phage resistance under
different temperature conditions of infectivity assays.
By using quantitative PCR (qPCR) we compared cas3
transcript levels between hns+ and Δhns cells in both
mid-log and stationary phases of growth. Relative abun-
dance of cas3 transcripts was around eight-fold higher
in Δhns cells compared to hns+ cells when grown to sta-
tionary phase, regardless of the temperature being 30 °C
or 37 °C (8.99 ± 3.83 and 7.59 ± 1.59), but remained simi-
lar at mid-log phase (0.9 ± 0.56 and 2.44 ± 1.21 for 30 °C
and 37 °C, respectively). This suggested that the growth
phase was important for the observed difference in the
level of cas3 transcripts, not the temperature of incuba-
tion. As shown in Fig. 1, only Δhns + λT3 cells showed
significant difference in cas3 transcripts depending on
the temperature of incubation (marked with different
letters d and bc which indicate significant difference in
expression values between these two samples (p < 0.05)).
Increased cas3 transcription at stationary phase at 30 °C
or 37 °C was not observed if H-NS was present, and
presence of λc + λT3 spacers had no effect on cas3 tran-
script levels (Fig. 1). These results suggest that the sensi-
tivity of Δhns cells to λvir plaques at 37 °C is unlikely to
be due to lack of cas3 transcription. We therefore tested
if Cas3 protein levels may influence phage sensitivity at
37 °C. The chaperone HtpG was also considered here,
because HtpG increases steady-state Cas3 protein levels
in E. coli, which correlated to stimulation of interference
reactions, carried out at 32 °C [41]. We reasoned that
sensitivity of Δhns Δcas1 + λc + λT3 cells to λvir at 37 °C
caused by reduced or unstable Cas3 protein might be
Table 1 E. coli cells lacking H-NS show temperature-dependent resistance to phage
strain genotype Plaque forming units (PFUs)
30 °C 37 °C
BW25113 hns+ 3.80 × 1010 ± 7 × 109 4.56 × 1010 ± 9 × 109
BW39121 Δhns 1.20 × 1010 ± 1.8 × 109 4.23 × 1010 ± 6.6 × 1010
BW39651 hns+ + λT3 3.66 × 1010 ± 7.57 × 109 4.03 × 1010 ± 1.2 × 1010
BW39671 Δhns + λT3 ~4 × 105 4.16 × 1010 ± 5.5 × 109
λvir
Cell lawns were infected with phage dilutions (from 10−2 to 10−8) and incubated at either 30 °C or 37 °C. Cells lacking H-NS (Δhns) or containing H-NS (hns+) had
fully operational CRISPR-Cas systems that were engineered with an anti-λ spacer (λT3) as indicated. The average of at least three independent experiments
are shown
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overcome by plasmid expression of HtpG or Cas3. How-
ever, we observed that (Fig. 2a) expression of only Cas3
from plasmid restored resistance of Δhns Δcas1 + λc + λT3
cells to λvir at 37 °C comparably to at 30 °C, while cells
containing empty plasmid vectors (pBAD or pUC19) or
HtpG expressing plasmid remained sensitive. These results
suggest that endogenous levels of functionally active Cas3
in Δhns Δcas1 + λc + λT3 cells are too low to be relieved by
elevated levels of HtpG at 37 °C. Given the importance of
HtpG for phage resistance it was expected that elimination
of HtpG from Δhns Δcas1 + λc + λT3 cells (ΔhtpG Δhns
Δcas1 + λc + λT3) would cause sensitivity to phage at both
30 °C and 37 °C (Fig. 2b), compared to phage resistance ob-
served in Fig. 2a. Indeed, plaques were observed at 30 °C in
ΔhtpG Δhns Δcas1 + λc + λT3 cells with or without empty
plasmid controls. However, individual plaques were
not visible, so the number of PFU is estimation
(Fig. 2b). Plasmid expression of Cas3 (pCas3) in
ΔhtpG Δhns Δcas1 + λc + λT3 cells was sufficient for
phage resistance at 30 °C (Fig. 2b) indicating that ele-
vated amounts of Cas3 is efficient in phage defence
independently of HtpG at 30 °C as shown before [41].
In contrast, elevated levels of Cas3 (pCas3) in ΔhtpG
Δhns Δcas1 + λc + λT3 cells did not rescue phage re-
sistance at 37 °C confirming the importance of HtpG
in maintaining functional levels of Cas3 in phage de-
fence. As expected, although plasmid expression of
HtpG (pHtpG) in ΔhtpG Δhns + λc + λT3 cells rescued
phage resistance at 30 °C, it did not at 37 °C (Fig. 2b).
Given the known interplay of HtpG and Cas3 in pro-
moting CRISPR interference in E. coli, these results
suggest that levels of Cas3 protein are the limiting
factor for resistance to λvir phage infection in Δhns
cells at 37 °C. Overall, these results show that endogenous
levels of Cas3 are expressed in low but sufficient amounts
for the CRISPR-Cas mediated immunity in cells lacking H-
NS grown to stationary phase at 30 °C, but that the levels
of functionally active Cas3 becomes limiting at 37 °C and
require increased levels of Cas3.
Discussion
By manipulating the expression of H-NS and CRISPR-
Cas in E. coli cells we identified that stability or activity
of Cas3, with HtpG present, is a limiting factor for re-
sistance to phage λvir at 37 °C. Our genetic analyses of
CRISPR interference at 30 °C agreed with previous stud-
ies, by observing robust phage resistance when cells
were lacking H-NS repressor (Δhns), and when an anti-λ
spacer could target protospacer DNA next to a consen-
sus PAM, 5′-CTT-3′. However, the same assays at 37 °C
resulted in a dramatic loss of phage resistance that had
not been observed previously. Phage resistance could be
restored at 37 °C, to levels comparable with resistance at
30 °C, by inducible expression of cas3 from plasmids.
Previous analyses of cas3 transcription sampled only
during mid-log growth and showed no difference be-
tween Δhns cells compared to hns+ cells, unlike Cascade
genes and crRNA that were much increased in Δhns
cells [34]. We measured cas3 transcripts in mid-log and
stationary phase, observing that Δhns cells contained
eight-fold more cas3 transcript compared to hns+ cells at
Table 3 Temperature-dependent resistance of Δhns cells to phage λvir in the presence of phage acquired spacer
strain genotype Plaque forming units (PFUs)
30 °C 37 °C
IIB965 hns+ Δcas1 + λT3 4.63 × 1010 ± 1.6 × 1010 5.8 × 1010 ± 1.14 × 1010
IIB966 Δhns Δcas1 + λT3 ~5 × 105 3.35 × 1010 ± 9 × 109
IIB1039 hns+ Δcas1 + λc + λT3 3.37 × 1010 ± 2.5 × 109 2.97 × 1010 ± 9.7 × 109
IIB1040 Δhns Δcas1 + λc + λT3 ~ 3 × 102 2 × 1010 ± 6 × 109
Cell lawns of strains hns+ (Δcas1) + λc + λT3 and Δhns (Δcas1) + λc + λT3 were infected with phage dilutions (from 100 to 10−8) and incubated at either 30 °C or
37 °C. The average of at least three independent experiments are shown
Fig. 1 Cas3 is transcribed in cells lacking H-NS at both temperatures
of incubation in stationary phase of growth. qPCR analysis extended
to Δhns Δcas1 and hns+ Δcas1 cells containing λT3 and/or λc
anti-lambda spacer. Relative expression levels of cas3 transcripts are
measured in cells grown to stationary phase at indicated temperatures
of incubation with groES as reference gene. Error bars represent
normalized error of respective duplicates. Histogram bars marked with
different letters (a for hns+ samples, and b, bc, cd and d for Δhns
samples) indicate significant difference between expression values,
while samples that share a letter in the notation (e.g. b, bc, cd or d and
cd) do not have statistically different expression values. Cas3 expression
levels were compared across all samples, and two expression values
were considered significantly different as evaluated by One-way
ANOVA Duncan Multiple Range post-hoc test (p < 0.05)
Majsec et al. BMC Microbiology  (2016) 16:28 Page 5 of 9
30 °C and 37 °C. This is significant because infectivity
assays for measuring resistance of E. coli to λvir use cells
in stationary phase. We conclude from this analysis that
H-NS regulates expression of the cas3 gene, as well as
Cascade and crRNA, but possibly does so under more
specific growth conditions.
Recently it was highlighted that Cas3 requires HtpG
chaperone for CRISPR interference assays [41]: Overex-
pression of HtpG or Cas3 from plasmids in htpG deficient
cells (ΔhtpG Δhns) rescued transformation-efficiency at
32 °C. We observed similar interplay of HtpG and Cas3 at
30 °C because plasmid overexpression of either HtpG or
Cas3 (pHtpG/pCas3) could restore phage resistance to
ΔhtpG Δhns Δcas1 + λc + λT3 (IIB1066) cells that were
otherwise sensitive to phage infection (Fig. 2b). Interest-
ingly, the pCas3 alone did not restore phage resistance to
ΔhtpG Δhns Δcas1 + λc + λT3 cells at 37 °C (Fig. 2b) but
did to htpG+ Δhns Δcas1 + λc + λT3 (IIB1040) cells at 37 °C
(Fig. 2a), while pHtpG was unable to sustain phage resist-
ance to any Δhns cells at 37 °C. Thus, HtpG is important
for CRISPR-system activity in Δhns cells at 37 °C, but its
overexpression from plasmid alone cannot overcome limit-
ing amounts of functionally active Cas3 at 37 °C. Further
research will be required to better understand the reasons
and mechanisms of Cas3 instability in Δhns cells at 37 °C.
In addition to four σ70 (“house-keeping” sigma factor)-
promoters in CRISPR-Cas area, two potential σ32 (heat-
shock sigma factor)-dependent promoters have been
mapped within coding regions of cas7 and cas1 [42, 43],
suggesting another possible link between CRISPR-Cas im-
munity and heat-shock response. In summary, expression
and activity of the CRISPR-Cas system in E. coli seem to
Fig. 2 HtpG is required for resistance to λvir at 30 °C and 37 °C to prevent Cas3 instability. a E. coli cell lawns of strain Δhns Δcas1 + λc + λT3
(IIB1040) transformed with pCas3 and pHtpG expressing plasmids and empty vector controls were infected with phage dilutions (from 100 to
10−8) and incubated at 37 °C. Bars represent average and SD of the number of plaque forming units (PFUs) per ml from three independent
experiments. b E. coli cell lawns of strains Δhns Δcas1 + λc + λT3 (IIB1040) and ΔhtpG Δhns Δcas1 + λc + λT3 (IIB1066) and IIB1066 transformed
with pCas3 and pHtpG expressing plasmids, were infected with phage dilutions (from 100 to 10−8) and incubated at either 30 °C or 37 °C. Bars
represent average and SD of the number of plaque forming units (PFUs) per ml from three independent experiments
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be linked to global stress responses, such as H-NS global
repressor, heat stress and CRP-cAMP. Perhaps, CRISPR-
Cas immunity is designed to become activated during cer-
tain phase of growth, at specific environmental habitats
and temperature, and instability of the Cas3 may be the
mechanism for inactivation of the CRISPR-Cas defence ei-
ther at inappropriate temperature of incubation or when
degradation of foreign DNA is completed.
Conclusions
We observed that the ability of an E. coli CRISPR-Cas sys-
tem to resist lysis by phage λ was strongly influenced by
temperature. Genetic analysis of this effect indicated that
sensitivity to phage at 37 °C was caused by limiting
amounts of Cas3, rather than effects of PAM sequence
variations on Cascade interference reactions. We show
that transcription of cas3 is controlled by H-NS: elimin-
ation of H-NS from cells correlated to eight-fold increased
levels of cas3 transcript, specifically in stationary phase
growth. At 37 °C, increased expression of cas3 is required
for resistance to λ infection. This suggests that endogen-
ous expression and activity of Cas3 is responsive to signals
associated with growth phase and temperature in E. coli.
Methods
Strains and plasmids
The E. coli K-12 strains used in this study are described
in the Table 2.
Plasmids used were: pEB526 expressing Cas3 [44], and
HtpG expressing plasmid was from pBAD18 plasmid [41].
Media and general methods
LB broth and agar media (10 g L−1 bacto-tryptone, 5 g L−1
yeast extract, 10 g L−1NaCl), supplemented with 15 g of
agar for solid media. When required appropriate antibi-
otics were added to LB plates at final concentrations:
ampicillin at 100 μg/ml, kanamycin at 40 μg/ml, apramy-
cin 30 μg/ml and chloramphenicol at 15 μg/ml. Mutant
bacterial strains were made by P1vir transduction and
selected for the appropriate antibiotic resistance [45].
When important (for generating IIB969 and IIB1039), the
genotype (presence of λT3 and λc spacers) of many trans-
ductants were screened by colony PCR using the same
primers (CRISPR I-R: 5′-GAGATGCAGGCCATCGGA-
3′ and spacer 4: 5′-GCGACCGCTCAGAAATTCCA
GACCCGATCCAAA-3′) as for spacer acquisition and
PCR products were sequenced for confirmation.
Phage sensitivity assay by plaque formation
Cells were grown to saturation overnight in LB medium
supplemented with 0.02 % maltose. LB plates were over-
laid with 3.5 ml 0.6 % LB top agar containing 0.2 ml of
cells. After solidification, 10 μl aliquots of serially diluted
phages in 10 mM MgSO4 were spotted on the surface of
the plate and allowed to soak. Plates were incubated
overnight at 30 °C or 37 °C. When required, 1 mM IPTG
(isopropyl-β-D-thiogalactoside) and 0.2 % L-arabinose
were added in plates and top agar. The sensitivity of the
cells to infection was represented as the plaque-forming
units (PFUs) by counting plaques from several dilutions,
and calculating their number per mL.
Spacer acquisition experiments to generate a consensus
PAM for interference
Spacer acquisition was performed according to [27].
Strain IIB969 with cas genes fused to inducible pro-
moters and containing the anti-lambda λT3 spacer in
CRISPR locus 2.1 (Table 2) was grown at 37 °C at
200 rpm to log phase in LB medium containing 1 mM
IPTG and 0.2 % L-arabinose until OD600 was 0.4-0.5,
and mixed with λvir lysate at appropriate MOI = 1. Cell-
phage mixture was incubated for 15 minutes without
agitation at 37 °C. The mixture was then diluted 10 fold
with fresh LB medium containing the same inducers and
incubated at 37 °C for at least two hours, in most cases
overnight. Aliquots were spread on LB plates with IPTG
and arabinose and incubated overnight at 37 °C. CRISPR
expansion was monitored by PCR using appropriate pairs
of primers specific for CRISPR locus 2.1 mentioned above.
Several PCR products of fragments of CRISPR locus
2.1 (Additional file 1: Figure S1B) were sent for sequen-
cing in Macrogene service. One lambda resistant deriva-
tive was kept for further research (IIB969e, Table 2). It
contained phage-acquired anti-λ spacer targeting λcII
gene (called λc) with consensus PAM 5′-CTT-3′
(Additional file 1: Figure S1C). Δhns + λc + λT3 strain
was made by P1 transduction using donor strain Δcas1::
Kmr (BW39183) and selecting for hns+ recombinant
strain with two extra spacers in the CRISPR locus 2.1
(strain IIB1039; Table 2) and later introducing Δhns mu-
tation (strain IIB1040; Table 2). The Δcas1 mutation was
chosen to create Δhns + λc + λT3 cells because cas1 gene
is not required for interference [37].
RNA extraction and qPCR
Total RNA was extracted from mid log (OD600 = 0.4-0.5)
and overnight cultures incubated at 30 °C or 37 °C.
1.5 ml of each culture was used and the cell pellet was
resuspended in cold 10 mM EDTA and 50 mM sodium
citrate and Trizol LS (Invitrogen) was used to extract
total RNA following the instructions from the manufac-
turer. The same amounts of RNA (1 μg) was first treated
by DNase I, diluted 10 fold and 2 μl of each sample (in
duplicate) was used as a template for one step amplifica-
tion reaction using One Step SYBR Prime Script RT-
PCR Kit II (Takara Bio. Inc.). The PCR reactions were
performed on a 7500 Fast Real Time PCR System (Ap-
plied Biosystems) and analysed using 7500 Software
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v.2.0.6. (Applied Biosystems). As an internal control the
groES gene was used. Fold change of the cas3 gene tran-
scription was calculated using relative quantification
with groES as endogenous control and cas3 gene tran-
script from E. coli BW25113 (wild type) abundance as
calibrator. All PCR reactions were performed in tripli-
cate. Control PCRs without template were performed to
monitor general contamination levels. Results of qPCR
(ΔCt values) were analyzed by one-way analysis of variance
(ANOVA) using STATISTICA 12.0 (StatSoft Inc, USA)
software package. Duncan Multiple Range Test was used
for post-hoc analysis. Differences between two sample
means were considered statistically significant at p < 0.05.
Primers used were:
Cas 3-F: 5′-ATCGCGTCAATGTACCCTTC-3′
Cas3-R: 5′-TCCAGCCAAAGTAACCCATC-3′
groES-F: 5′-CTG GAT CGT CAA GCG TAA AG-3′
groES-R: 5′-CAA GGA TAC GGC CAT TGC-3′
Additional file
Additional file 1: Figure S1. Properties of PAM in λT3 spacer and phage
acquired spacer (A). Sequence complementarity between λT3 spacer and
proto-spacer in lambda with the PAM 5′ CCA 3′ highlighted in red type. (B)
Detection of new spacers acquired in CRISPR locus 2.1. The agarose gel
shows products of PCR amplified CRISPR 2.1 from E. coli cells IIB969 (lane C
“control”), and two phage resistant derivatives after phage challenge of
IIB969 (lanes a and b). The PCR fragment size is 723 bp before and 784 bp
after spacer acquisition (C). λc spacer sequence from the strain IIB969e is
presented paired with proto-spacer in lambda (targeting gene cII) with the
PAM 5′-CTT-3′ highlighted in red type. (JPG 311 kb)
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